Q2 2026 Holdings
Filed 2026-07-22 | 8 holdings | $206.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kestra MED Technologies LTD(KMTS) | SHS | G52441105 | $69.4M | 2,728,679 | 33.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $42.9M | 1,591,917 | 20.8% |
| Avalyn Pharmaceuticals Inc(AVLN) | COM SHS | 05348Y105 | $30.6M | 929,824 | 14.8% |
| Agomab Therapeutics NV(AGMB) | SPONSORED ADS | 00860C102 | $20.0M | 1,538,702 | 9.7% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $18.5M | 1,391,990 | 9.0% |
| Inventiva SA(IVA) | ADS | 46124U107 | $13.7M | 3,633,181 | 6.7% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $10.4M | 78,125 | 5.0% |
| Nyxoah S A(NYXH) | SHS | B6S7WD106 | $882.3K | 522,057 | 0.4% |